(Q38303354)

1 September 2017

title

MiR-124 retards bladder cancer growth by directly targeting CDK4. (English)

1 reference

1 September 2017

1 reference

Ting Zhang

1

1 reference

1 September 2017

Jingyao Wang

2

1 reference

1 September 2017

Xiaofeng Zhai

3

1 reference

1 September 2017

Hongjie Li

4

1 reference

1 September 2017

Changying Li

5

1 reference

1 September 2017

Jiwu Chang

6

1 reference

1 September 2017

publication date

27 October 2014

1 reference

Acta Biochimica et Biophysica Sinica

1 September 2017

published in

1 reference

1 September 2017

volume

46

1 reference

1 September 2017

issue

12

1 reference

1 September 2017

page(s)

1072-1079

1 reference

IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MicroRNA-124-mediated regulation of inhibitory member of apoptosis-stimulating protein of p53 family in experimental stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

Adult neurogenesis in the short-lived teleost Nothobranchius furzeri: localization of neurogenic niches, molecular characterization and effects of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

miR-124 represses ROCK1 expression to promote neurite elongation through activation of the PI3K/Akt signal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

miR-124 radiosensitizes human glioma cells by targeting CDK4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMU105

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMU105

1 reference

1 September 2017

1 reference